Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

Small Study Hints at Mechanism for COVID-Related MI and Stroke

L.A. McKeown

October 02, 2023

News Daily News

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Caitlin E. Cox

July 08, 2022

News Daily News

In Adults, CV Pathology Dominates COVID-19 Multisystem Inflammatory Syndrome

Shelley Wood

September 23, 2021

News Conference News ACC 2021

For Younger MI Survivors, Stress Boosts Adverse Outcomes

Caitlin E. Cox

May 13, 2021

News Daily News

Tocilizumab Improves Myocardial Salvage After STEMI: ASSAIL-MI

Michael O'Riordan

April 12, 2021

News Daily News

Pills for Erectile Dysfunction Linked to Fewer CVD Deaths

Caitlin E. Cox

March 24, 2021

News Daily News

E-Cigs in Combination With Cigarettes Don’t Cut Markers of CV Risk

Todd Neale

January 05, 2021

News Conference News AHA 2020

Childhood Stress, Trauma Linked to Worse Outcomes After Early MI

L.A. McKeown

November 16, 2020

News Conference News TCT 2020

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

L.A. McKeown

October 26, 2020

News Daily News

Don’t Mistake Microthrombi for Myocarditis in COVID-19 STEMI, Case Report Warns

Caitlin E. Cox

July 22, 2020

News Daily News

COVID-19’s Kawasaki-Like MIS-C Diagnosis Is Cropping Up in Adults

Shelley Wood

July 22, 2020

News Daily News

Even Very Sick Kids Fare Well Despite Kawasaki-Like COVID-19 Symptoms

Todd Neale

May 21, 2020

News Features

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Caitlin E. Cox

April 23, 2020

News Daily News

Omega-3 PUFAs Offset Adverse CV Effects of Air Pollution in Small, Chinese Study

Michael O'Riordan

April 24, 2019

News Conference News AHA 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Michael O'Riordan

November 10, 2018

News Daily News

ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World

Caitlin E. Cox

May 16, 2018

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

Advertisement

Small Study Hints at Mechanism for COVID-Related MI and Stroke

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

In Adults, CV Pathology Dominates COVID-19 Multisystem Inflammatory Syndrome

For Younger MI Survivors, Stress Boosts Adverse Outcomes

Tocilizumab Improves Myocardial Salvage After STEMI: ASSAIL-MI

Pills for Erectile Dysfunction Linked to Fewer CVD Deaths

E-Cigs in Combination With Cigarettes Don’t Cut Markers of CV Risk

Childhood Stress, Trauma Linked to Worse Outcomes After Early MI

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

Don’t Mistake Microthrombi for Myocarditis in COVID-19 STEMI, Case Report Warns

COVID-19’s Kawasaki-Like MIS-C Diagnosis Is Cropping Up in Adults

Even Very Sick Kids Fare Well Despite Kawasaki-Like COVID-19 Symptoms

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Omega-3 PUFAs Offset Adverse CV Effects of Air Pollution in Small, Chinese Study

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

ESC Consensus Statement Tackles Inflammation, Cholesterol Connection in a Post-CANTOS World

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content